ABBOTT LABORATORIES | 2013 | FY | 3


Note 15 — Quarterly Results (Unaudited)

(in millions except per share data)

 
  2013   2012  

First Quarter

             

Continuing Operations:

             

Net Sales

  $ 5,378   $ 5,284  

Gross Profit

    2,747     2,716  

Earnings from Continuing Operations

    545     351  

Basic Earnings per Common Share

    0.35     0.22  

Diluted Earnings per Common Share

    0.34     0.22  

Net Earnings

    545     1,242  

Basic Earnings Per Common Share (a)

    0.35     0.79  

Diluted Earnings Per Common Share (a)

    0.34     0.78  

Market Price Per Share-High (b)

    35.34     29.42  

Market Price Per Share-Low (b)

    31.64     25.82  

Second Quarter

   
 
   
 
 

Continuing Operations:

             

Net Sales

  $ 5,446   $ 5,313  

Gross Profit

    2,704     2,748  

Earnings from Continuing Operations

    476     411  

Basic Earnings per Common Share

    0.30     0.26  

Diluted Earnings per Common Share

    0.30     0.26  

Net Earnings

    476     1,725  

Basic Earnings Per Common Share (a)

    0.30     1.09  

Diluted Earnings Per Common Share (a)

    0.30     1.08  

Market Price Per Share-High (b)

    38.77     30.85  

Market Price Per Share-Low (b)

    34.69     28.25  

Third Quarter

   
 
   
 
 

Continuing Operations:

             

Net Sales

  $ 5,369   $ 5,265  

Gross Profit

    2,722     2,581  

Earnings from Continuing Operations

    773     339  

Basic Earnings per Common Share

    0.50     0.21  

Diluted Earnings per Common Share

    0.49     0.21  

Net Earnings

    966     1,943  

Basic Earnings Per Common Share (a)

    0.62     1.22  

Diluted Earnings Per Common Share (a)

    0.61     1.21  

Market Price Per Share-High (b)

    37.16     33.69  

Market Price Per Share-Low (b)

    32.70     30.39  

Fourth Quarter

   
 
   
 
 

Continuing Operations:

             

Net Sales

  $ 5,655   $ 5,632  

Gross Profit

    2,844     2,837  

Earnings (loss) from Continuing Operations

    589     (522 )

Basic Earnings per Common Share

    0.38     (0.33 )

Diluted Earnings per Common Share

    0.37     (0.33 )

Net Earnings

    589     1,053  

Basic Earnings Per Common Share (a)

    0.38     0.66  

Diluted Earnings Per Common Share (a)

    0.37     0.66  

Market Price Per Share-High (b)

    38.81     34.67  

Market Price Per Share-Low (b)

    32.75     29.96  

(a)
The sum of the four quarters' of earnings per share for 2013 and 2012 may not add to the full year earnings per share amount due to rounding and/or the use of quarter-to-date weighted average shares to calculate the earnings per share amount in each respective quarter.

(b)
The 2012 market prices per share reflect historical share prices that have been adjusted to reflect the separation of AbbVie.

us-gaap:QuarterlyFinancialInformationTextBlock